ExodusPoint Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-49,817
| Closed | -$3.27M | – | 1405 |
|
|
2024
Q4 | $3.27M | Sell |
49,817
-28,494
| -36% | -$1.87M | 0.02% | 520 |
|
|
2024
Q3 | $5.5M | Buy |
+78,311
| New | +$5.5M | 0.03% | 355 |
|
|
2023
Q4 | – | Sell |
-170,017
| Closed | -$15M | – | 1431 |
|
|
2023
Q3 | $15M | Sell |
170,017
-59,626
| -26% | -$5.28M | 0.14% | 125 |
|
|
2023
Q2 | $19.9M | Buy |
229,643
+51,707
| +29% | +$4.48M | 0.16% | 91 |
|
|
2023
Q1 | $17.3M | Buy |
177,936
+59,730
| +51% | +$5.81M | 0.14% | 125 |
|
|
2022
Q4 | $12.2M | Sell |
118,206
-75,610
| -39% | -$7.82M | 0.18% | 124 |
|
|
2022
Q3 | $16.4M | Buy |
193,816
+82,346
| +74% | +$6.98M | 0.21% | 90 |
|
|
2022
Q2 | $9.24M | Buy |
111,470
+90,341
| +428% | +$7.49M | 0.11% | 194 |
|
|
2022
Q1 | $1.63M | Sell |
21,129
-19,648
| -48% | -$1.51M | 0.02% | 832 |
|
|
2021
Q4 | $3.6M | Buy |
40,777
+32,789
| +410% | +$2.9M | 0.04% | 515 |
|
|
2021
Q3 | $617K | Buy |
+7,988
| New | +$617K | 0.01% | 1227 |
|
|
2021
Q2 | – | Sell |
-16,748
| Closed | -$1.27M | – | 2285 |
|
|
2021
Q1 | $1.27M | Sell |
16,748
-9,706
| -37% | -$733K | 0.02% | 749 |
|
|
2020
Q4 | $2.32M | Sell |
26,454
-13,494
| -34% | -$1.18M | 0.02% | 450 |
|
|
2020
Q3 | $3.04M | Sell |
39,948
-97,708
| -71% | -$7.43M | 0.06% | 246 |
|
|
2020
Q2 | $17M | Buy |
137,656
+126,125
| +1,094% | +$15.6M | 0.44% | 23 |
|
|
2020
Q1 | $974K | Buy |
+11,531
| New | +$974K | 0.05% | 275 |
|
|
2019
Q4 | – | Sell |
-4,600
| Closed | -$310K | – | 1483 |
|
|
2019
Q3 | $310K | Buy |
+4,600
| New | +$310K | 0.01% | 832 |
|